W.R. Berkley Corp’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

W.R. Berkley Corp’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23,071	Closed	-$483K	–	94
2016 Q3	$483K	Buy	+23,071	New	+$266K	0.05%	71

W.R. Berkley Corp's VTAE Position: Q4 2016 in Review

W.R. Berkley Corp sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 23,071 shares — an estimated $483K sold.

W.R. Berkley Corp first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $483K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

W.R. Berkley Corp reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
W.R. Berkley Corp sold 23,071 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $483K.
W.R. Berkley Corp first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
W.R. Berkley Corp's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $483K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on W.R. Berkley Corp's 13F filing for Q4 2016, filed 14 Feb 2017.